Literature DB >> 22983921

Spinal cord injury-induced osteoporosis: pathogenesis and emerging therapies.

Ricardo A Battaglino1, Antonio A Lazzari, Eric Garshick, Leslie R Morse.   

Abstract

Spinal cord injury causes rapid, severe osteoporosis with increased fracture risk. Mechanical unloading after paralysis results in increased osteocyte expression of sclerostin, suppressed bone formation, and indirect stimulation of bone resorption. At this time, there are no clinical guidelines to prevent bone loss after SCI, and fractures are common. More research is required to define the pathophysiology and epidemiology of SCI-induced osteoporosis. This review summarizes emerging therapeutics including anti-sclerostin antibodies, mechanical loading of the lower extremity with electrical stimulation, and mechanical stimulation via vibration therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22983921      PMCID: PMC3508135          DOI: 10.1007/s11914-012-0117-0

Source DB:  PubMed          Journal:  Curr Osteoporos Rep        ISSN: 1544-1873            Impact factor:   5.096


  85 in total

1.  Longitudinal changes in bone in men with spinal cord injury.

Authors:  E D de Bruin; V Dietz; M A Dambacher; E Stüssi
Journal:  Clin Rehabil       Date:  2000-04       Impact factor: 3.477

2.  Long-term changes in the tibia and radius bone mineral density following spinal cord injury.

Authors:  E D de Bruin; B Vanwanseele; M A Dambacher; V Dietz; E Stüssi
Journal:  Spinal Cord       Date:  2005-02       Impact factor: 2.772

3.  Mechanical stimulation of mesenchymal stem cell proliferation and differentiation promotes osteogenesis while preventing dietary-induced obesity.

Authors:  Yen Kim Luu; Encarnacion Capilla; Clifford J Rosen; Vicente Gilsanz; Jeffrey E Pessin; Stefan Judex; Clinton T Rubin
Journal:  J Bone Miner Res       Date:  2009-01       Impact factor: 6.741

4.  Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength.

Authors:  Michael S Ominsky; Fay Vlasseros; Jacquelin Jolette; Susan Y Smith; Brian Stouch; George Doellgast; Jianhua Gong; Yongming Gao; Jin Cao; Kevin Graham; Barbara Tipton; Jill Cai; Rohini Deshpande; Lei Zhou; Michael D Hale; Daniel J Lightwood; Alistair J Henry; Andrew G Popplewell; Adrian R Moore; Martyn K Robinson; David L Lacey; W Scott Simonet; Chris Paszty
Journal:  J Bone Miner Res       Date:  2010-05       Impact factor: 6.741

5.  Downregulation of SOST/sclerostin by PTH: a novel mechanism of hormonal control of bone formation mediated by osteocytes.

Authors:  T Bellido
Journal:  J Musculoskelet Neuronal Interact       Date:  2006 Oct-Dec       Impact factor: 2.041

Review 6.  A review of body mass index and waist circumference as markers of obesity and coronary heart disease risk in persons with chronic spinal cord injury.

Authors:  A C Buchholz; J M Bugaresti
Journal:  Spinal Cord       Date:  2005-09       Impact factor: 2.772

Review 7.  Inhibition of cathepsin K for treatment of osteoporosis.

Authors:  Steven Boonen; Elizabeth Rosenberg; Frank Claessens; Dirk Vanderschueren; Socrates Papapoulos
Journal:  Curr Osteoporos Rep       Date:  2012-03       Impact factor: 5.096

8.  Sclerostin antibody treatment increases bone formation, bone mass, and bone strength in a rat model of postmenopausal osteoporosis.

Authors:  Xiaodong Li; Michael S Ominsky; Kelly S Warmington; Sean Morony; Jianhua Gong; Jin Cao; Yongming Gao; Victoria Shalhoub; Barbara Tipton; Raj Haldankar; Qing Chen; Aaron Winters; Tom Boone; Zhaopo Geng; Qing-Tian Niu; Hua Zhu Ke; Paul J Kostenuik; W Scott Simonet; David L Lacey; Chris Paszty
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

9.  Plasma adiponectin and insulin sensitivity in overweight and normal-weight middle-aged premenopausal women.

Authors:  Jaak Jürimäe; Toivo Jürimäe; Susanne Ring-Dimitriou; Linda M LeMura; Paul J Arciero; Serge P von Duvillard
Journal:  Metabolism       Date:  2009-05       Impact factor: 8.694

10.  Time-course response in serum markers of bone turnover to a single-bout of electrical stimulation in patients with recent spinal cord injury.

Authors:  Alfredo Arija-Blázquez; Silvia Ceruelo-Abajo; María S Díaz-Merino; Juan Antonio Godino-Durán; Luís Martínez-Dhier; José Florensa-Vila
Journal:  Eur J Appl Physiol       Date:  2012-05-11       Impact factor: 3.078

View more
  39 in total

1.  Characterization of unexpected postural changes during robot-assisted gait training in paraplegic patients.

Authors:  S Koyama; S Tanabe; E Saitoh; S Hirano; Y Shimizu; M Katoh; A Uno; T Takemitsu
Journal:  Spinal Cord       Date:  2015-08-11       Impact factor: 2.772

2.  Mice with sclerostin gene deletion are resistant to the severe sublesional bone loss induced by spinal cord injury.

Authors:  W Qin; W Zhao; X Li; Y Peng; L M Harlow; J Li; Y Qin; J Pan; Y Wu; L Ran; H Z Ke; C P Cardozo; W A Bauman
Journal:  Osteoporos Int       Date:  2016-07-20       Impact factor: 4.507

Review 3.  Bone Imaging and Fracture Risk after Spinal Cord Injury.

Authors:  W Brent Edwards; Thomas J Schnitzer
Journal:  Curr Osteoporos Rep       Date:  2015-10       Impact factor: 5.096

4.  Effect of whole-body vibration on lower-limb EMG activity in subjects with and without spinal cord injury.

Authors:  Milad Alizadeh-Meghrazi; Kei Masani; José Zariffa; Dimitry G Sayenko; Milos R Popovic; B Catharine Craven
Journal:  J Spinal Cord Med       Date:  2014-07-01       Impact factor: 1.985

5.  Vibration training after chronic spinal cord injury: Evidence for persistent segmental plasticity.

Authors:  Chu-Ling Yen; Colleen L McHenry; Michael A Petrie; Shauna Dudley-Javoroski; Richard K Shields
Journal:  Neurosci Lett       Date:  2017-03-16       Impact factor: 3.046

6.  Surgical management of lower limb fractures in patients with spinal cord injury less associated with complications than non-operative management: A retrospective series of cases.

Authors:  Alban Fouasson-Chailloux; Raphael Gross; Marc Dauty; Guillaume Gadbled; Sophie Touchais; Marc Le Fort; Brigitte Perrouin-Verbe
Journal:  J Spinal Cord Med       Date:  2017-05-10       Impact factor: 1.985

7.  Whole-body vibration can attenuate the deterioration of bone mass and trabecular bone microstructure in rats with spinal cord injury.

Authors:  A Minematsu; Y Nishii; H Imagita; D Takeshita; S Sakata
Journal:  Spinal Cord       Date:  2015-12-22       Impact factor: 2.772

8.  Open-label clinical trial of alendronate after teriparatide therapy in people with spinal cord injury and low bone mineral density.

Authors:  Ifaz T Haider; Narina Simonian; Amanpreet S Saini; Frances M Leung; W Brent Edwards; Thomas J Schnitzer
Journal:  Spinal Cord       Date:  2019-06-04       Impact factor: 2.772

9.  Osteoporosis in adults with cerebral palsy: feasibility of DXA screening and risk factors for low bone density.

Authors:  C Marciniak; J Gabet; J Lee; M Ma; K Brander; N Wysocki
Journal:  Osteoporos Int       Date:  2015-11-17       Impact factor: 4.507

10.  Effect of kidney-reinforcing and marrow-beneficial Chinese medicine on bone metabolism-related factors following spinal cord injury in rats.

Authors:  DA-An Zhou; Yue Ning Deng; Lei Liu; Jian Jun Li
Journal:  Exp Ther Med       Date:  2016-04-27       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.